Centro Especialidades San Jose Obrero (Barbarela)
About Centro Especialidades San Jose Obrero (Barbarela)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Clinical Trials at Centro Especialidades San Jose Obrero (Barbarela)
During the past decade, Centro Especialidades San Jose Obrero (Barbarela) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
2018-04-05
2019-10-10
Completed
1,842
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
2018-11-20
2021-04-22
Completed
2,002
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Centro Especialidades San Jose Obrero (Barbarela)
According to Clinical.Site data, the most researched conditions in "Centro Especialidades San Jose Obrero (Barbarela)" are
"Type 2 Diabetes Mellitus" (2 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Centro Especialidades San Jose Obrero (Barbarela)" in a lesser frequency.
Clinical Trials Intervention Types at Centro Especialidades San Jose Obrero (Barbarela)
Most popular intervention types in "Centro Especialidades San Jose Obrero (Barbarela)" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Dulaglutide" (2 trials), "Tirzepatide" (2 trials) and "Insulin Glargine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Especialidades San Jose Obrero (Barbarela)
The vast majority of trials in "Centro Especialidades San Jose Obrero (Barbarela)" are
3 trials for "All" genders.
Clinical Trials Status at Centro Especialidades San Jose Obrero (Barbarela)
Currently, there are NaN active trials in "Centro Especialidades San Jose Obrero (Barbarela)".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Centro Especialidades San Jose Obrero (Barbarela),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro Especialidades San Jose Obrero (Barbarela), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".